ViewRay Inc
OTC:VRAYQ
ViewRay Inc
OTC:VRAYQ
Price:
0.0001
USD
Market Cap:
$183
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
ViewRay Inc
OTC:VRAYQ
|
US |
|
New China Life Insurance Company Ltd
SSE:601336
|
CN |
|
T
|
Thai Central Chemical PCL
SET:TCCC
|
TH |
|
S
|
SMI Vantage Ltd
SGX:Y45
|
SG |
|
IMP Powers Ltd
NSE:INDLMETER
|
IN |
|
Coloplast A/S
CSE:COLO B
|
DK |
|
Zhongchao Inc
NASDAQ:ZCMD
|
CN |
|
Vef AB (publ)
STO:VEFAB
|
SE |
|
Aquis Exchange PLC
LSE:AQX
|
UK |
|
R
|
Revitalist Lifestyle and Wellness Ltd
CNSX:CALM
|
US |
|
Smoore International Holdings Ltd
HKEX:6969
|
CN |
|
S
|
Shanghai Model Organisms Center Inc
SSE:688265
|
CN |
|
Skylark Holdings Co Ltd
TSE:3197
|
JP |
|
TOPPAN Holdings Inc
SWB:TPX
|
JP |
|
Fifth Third Bancorp
NASDAQ:FITB
|
US |
|
H
|
HengFeng Information Technology Co Ltd
SZSE:300605
|
CN |
|
M
|
micromobility.com inc
OTC:MCOM
|
US |
|
Knowles Corp
NYSE:KN
|
US |
Relative Value
There is not enough data to reliably calculate the relative value of VRAYQ.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
VRAYQ
Relative Value
Base Case
Not Available
Multiples Across Competitors
VRAYQ Competitors Multiples
ViewRay Inc Competitors
ViewRay Inc Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| US |
|
ViewRay Inc
OTC:VRAYQ
|
183 USD | 0 | -0 | 0.8 | 0.7 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
180.7B USD | 4.1 | 28 | 16.1 | 22.1 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
167.6B USD | 16.6 | 58.4 | 44.2 | 54.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
125.7B USD | 5 | 38.5 | 19.7 | 23.9 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
111.1B USD | 3.2 | 24.5 | 13.5 | 19.7 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
101.1B USD | 5.1 | 35.5 | 20.9 | 28 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.4B EUR | 1.8 | 19.7 | 11.1 | 15.6 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.4B USD | 7.9 | 44.6 | 24.5 | 26.8 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
45.5B USD | 10.7 | 43.3 | 30.7 | 33.9 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.4B USD | 2.1 | 25.7 | 10.1 | 17.1 | |
| US |
|
Resmed Inc
NYSE:RMD
|
33.2B USD | 6.1 | 22.2 | 15.6 | 17.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
